The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
This issue features a letter from associate editor Dr. Elias Jabbour, a feature on CAR-T point-of-care manufacturing, and a report from SOHO Spain.